Advanced Flower Capital (AFCG) Cash & Equivalents (2020 - 2026)

Advanced Flower Capital has reported Cash & Equivalents for 7 years, with the latest figure at $112.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 3297.25% year-over-year to $112.7 million; the trailing twelve-month figure through Mar 2026 stood at $112.7 million (up 3297.25% YoY), and the FY2025 full-year result was $38.6 million, down 62.74% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $112.7 million, up from $38.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $170.3 million in Q2 2024, with the low at $3.3 million in Q1 2025.
• Average Cash & Equivalents over 5 years is $76.1 million, with a median of $80.6 million recorded in 2023.
• Year-over-year, Cash & Equivalents sank 98.0% in 2025 and jumped 3297.25% in 2026.
• Tracing AFCG's Cash & Equivalents over 5 years: stood at $140.4 million in 2022, then tumbled by 35.61% to $90.4 million in 2023, then increased by 14.64% to $103.6 million in 2024, then sank by 62.74% to $38.6 million in 2025, then jumped by 192.01% to $112.7 million in 2026.
• The last three Cash & Equivalents figures came in at $112.7 million (Q1 2026), $38.6 million (Q4 2025), and $45.1 million (Q3 2025), per Business Quant data.

Peer Comparison